Latest 10-K annual reports

Innovative Eyewear reported a 63% revenue increase in 2025, driven by new smart eyewear lines and improved gross margins, despite ongoing net losses and internal control weaknesses.

Serina Therapeutics, a clinical-stage biotechnology company, reported a significant increase in net losses for 2025, alongside ongoing concerns about its ability to continue as a going concern, despite advancing its lead Parkinson's disease candidate, SER-252, into Phase 1b clinical trials and securing new capital.

ECB Bancorp, Inc. announced a significant increase in net income for the year ended December 31, 2025, driven by robust loan growth and expanded net interest margin.

Global Self Storage, Inc. reported a 1.4% increase in total revenues and a 0.6% rise in same-store net operating income for 2025, despite a slight decrease in net income and diluted earnings per share.

Nika Pharmaceuticals' latest 10-K filing reveals significant financial distress, including a going concern warning and ineffective internal controls, despite a reduced net loss.

PFS Bancorp, Inc. announced a significant increase in net income for the fiscal year ended December 31, 2025, driven by higher net interest income and reduced noninterest expenses.

Kaanapali Land, LLC reports a net loss for 2025, driven by wildfire recovery costs and legal disputes, despite a significant land sale.

Fidelity Solana Fund's 2025 annual report details its SOL staking strategy, significant asset growth, and regulatory clarity on Solana as a digital commodity.

FVCBankcorp, Inc. filed an amended 10-K to correct certification errors, while reporting a 46% increase in net income to $22.1 million for 2025, driven by higher net interest income and minority investment gains.

Hashdex Nasdaq CME Crypto Index ETF concludes its first fiscal year with $121.3 million in net assets, a 9.15% NAV decline, and a strategic index transition.

Oak Valley Bancorp reported a decrease in net income for 2025 to $23.9 million, down from $24.9 million in 2024, primarily due to increased non-interest expenses and a credit loss provision.

Chenghe Acquisition III Co., a blank check company, reported a net income of $1.088 million for 2025, primarily from trust account interest, as it continues its search for an initial business combination target in Asia.

First National Corporation announced a significant increase in net income and improved profitability for 2025, driven by the Touchstone Bankshares acquisition and enhanced net interest margin.

UTG, Inc. reported a significant drop in net income and total revenues for 2025, primarily driven by lower realized investment gains and a decrease in the fair value of equity securities compared to the prior year.

Juniata Valley Financial Corp. announced a 28.2% increase in net income and EPS for 2025, driven by robust loan growth and improved net interest margin.

Genesco Inc. reported a significant turnaround in Fiscal 2026, achieving net earnings of $13.3 million and a 4.8% increase in net sales, driven by strong performance in its Journeys Group.

Intrusion Inc. reported a 22.9% revenue increase to $7.1 million in 2025, driven by government contracts, but faced a larger net loss of $9.1 million and a going concern warning due to recurring losses and negative cash flows.

Nexalin Technology, Inc. reported significant operating losses and a going concern warning, alongside Nasdaq minimum bid price non-compliance, despite advancing its neurostimulation product pipeline.

USBC Inc. reported a significant net loss driven by Bitcoin price volatility while advancing its tokenized deposit initiative and securing a new $25 million loan facility.

Paysign, Inc. (PAYS) reported significant revenue and net income growth in 2025, fueled by expansion in its pharmaceutical and plasma industry programs and the acquisition of Gamma Innovation LLC.

QT Imaging Holdings, Inc. announced a significant revenue increase, uplisted to Nasdaq, and secured major distribution agreements in the Middle East, despite widening net losses for fiscal year 2025.

Chewy, Inc. announced a 6.2% increase in net sales to $12.6 billion for fiscal year 2025, alongside significant expansion in its pet healthcare services and a strategic acquisition.

Maze Therapeutics announced positive topline Phase 2 clinical data for MZE829 in kidney disease, alongside a significant net loss for 2025 and a new $200 million loan facility.

Kiora Pharmaceuticals reported a net loss of $10.8 million for 2025, driven by increased R&D spending on its KIO-104 and KIO-301 programs and an impairment charge, despite securing key partnerships and maintaining liquidity into late 2027.

byNordic Acquisition Corporation, a SPAC, faces substantial doubt about its ability to continue as a going concern after failing to complete a business combination and being delisted from Nasdaq.

Spectral AI, an AI medical diagnostics company, reported a reduced net loss in 2025 but a decline in revenue, while advancing its DeepView System towards commercialization with key regulatory approvals and significant government funding.

Commercial Bancgroup, Inc. reported an 18.4% increase in net income for 2025, driven by reduced interest expenses and strategic acquisitions, following its successful October IPO.

Fifth District Bancorp, Inc. reported a significant increase in net income to $4.1 million for the year ended December 31, 2025, driven by higher net interest income and a substantial gain on bank-owned life insurance proceeds.

Cayson Acquisition Corp, a SPAC, extended its business combination deadline to March 2027 and entered a merger agreement with Mango Financial Group Limited, but saw significant shareholder redemptions and reported internal control deficiencies.

Curis, Inc. reported a net loss of $7.6 million for 2025 and raised substantial doubt about its ability to continue as a going concern, despite recent financing and ongoing clinical trials for its lead drug candidate, emavusertib.